Product Categories
Country: | United States |
---|---|
Tel: | +1-781-999-5354 |
Mobile: | 7819995354 |
E-mail: | marketing@targetmol.com |
QQ: | |
Skype: | Chat Now! |
Address: | 36 Washington Street, Wellesley Hills |
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
Product Name | MF | CAS | Details |
---|
Palbociclib-d8;Palbociclib D8;PD 0332991 D8 | C24H21D8N7O2 | 1628752-83-9 | Details |
Palmitoylcarnitine | C23H45NO4 | 1935-18-8 | Details |
Paprotrain | C16H11N3 | 57046-73-8 | Details |
Palmitoyldocosahexaenoyl phosphatidylcholine | C46H80NO8P | 59403-54-2 | Details |
para-Nitroblebbistatin | C18H15N3O4 | 1621326-32-6 | Details |
Palonidipine | C29H34FN3O6 | 96515-73-0 | Details |
Pasireotide pamoate;SOM230 pamoate | C58 H66 N10 O9 . C23 H16 O6 | 396091-79-5 | Details |
Pargolol hydrochloride;Ko 1400 hydrochloride | C16H24ClNO3 | 36902-82-6 | Details |
Pasireotide L-aspartate salt;SOM230 L-aspartate | C62H73N11O13 | 396091-77-3 | Details |
Parsaclisib | C20H22ClFN6O2 | 1426698-88-5 | Details |
PARP-2-IN-1 | C21H19F4N5O3 | 2115698-83-2 | Details |
PARP14 inhibitor H10 | C24H27N7O7S | 2084811-68-5 | Details |
PARP/PI3K-IN-1 | 2337386-47-5 | Details |
Parcetasal | C17H15NO5 | 87549-36-8 | Details |
Pasireotide;SOM 320;SOM 230 | C58H66N10O9 | 396091-73-9 | Details |
PD-159020 | C32H25NO8 | 177904-00-6 | Details |
PD-1-IN-17 | C13H22N6O7 | 1673560-66-1 | Details |
CA-170;PD-1-IN-1 | C12H20N6O7 | 1673534-76-3 | Details |
PAT-1251 Hydrochloride | C18H18ClF4N3O3 | 2098884-53-6 | Details |
Azathioprine | C9H7N7O2S | 446-86-6 | Details |
PAT-505 | C23H18ClF2N3O2S | 1782070-22-7 | Details |
Paxilline | C27H33NO4 | 57186-25-1 | Details |
PD-1-IN-22 | C25H25N5O4 | 2349372-98-9 | Details |
PAβN dihydrochloride | C25H32Cl2N6O2 | 100929-99-5 | Details |
PAT-1251 | C18H17F4N3O3 | 2007885-39-2 | Details |
PD-1/PD-L1-IN 5 TFA;PD-1/PD-L1-IN 5 | C24H19F3N4O5S | 2170209-52-4 | Details |
Fezagepras sodium | C13H19NaO2 | 1254472-97-3 | Details |
Daidzein | C15H10O4 | 486-66-8 | Details |
PC945 | C38H37F3N6O3 | 1931946-73-4 | Details |
PD 123319 ditrifluoroacetate | C33H33F3N4O5 | 136676-91-0 | Details |
PERK-IN-2 | C23H18F3N5O | 1337531-83-5 | Details |
PDD00031705 | C20H22N6O3S3 | 2032096-45-8 | Details |
PEPA | C16H16F2N2O4S2 | 141286-78-4 | Details |
Perhexiline maleate | C23H39NO4 | 6724-53-4 | Details |
PDE2/PDE10-IN-1 | C15H10ClN5 | 1426833-08-0 | Details |
PD-1-IN-18 | C11H17N5O8 | 1673534-97-8 | Details |
Pentiapine;CGS 10746 | C15H17N5S | 81382-51-6 | Details |
PDE-9 inhibitor | C22H27N5O2 | 1082743-70-1 | Details |
Peliglitazar racemate;BMS 426707-01 racemate | C30H30N2O7 | 331744-72-0 | Details |
PERK-IN-3 | C22H16F2N4O2 | 1337532-08-7 | Details |
PDE1-IN-3 | C18H24N4O | 2370966-46-2 | Details |
PDE5-IN-2 | C25H21N3O6S | 2244517-61-9 | Details |
Penitrem A | C37H44ClNO6 | 12627-35-9 | Details |
KP-23172 | C10H4N6O | 331253-86-2 | Details |
PD0176078 | C23H30F2N2O | 248922-46-5 | Details |
PD1-PDL1-IN 1 | C14H23N7O6 | 2005454-12-4 | Details |
PDK4-IN-1 | C22H19N3O2 | 2310262-10-1 | Details |
PD 90780 | C19H14N4O4 | 77422-99-2 | Details |
Pemigatinib;INCB054828 | C24H27F2N5O4 | 1513857-77-6 | Details |
PDGFRα kinase inhibitor 1 | C34H34N8O2 | 2209053-93-8 | Details |
PDE12-IN-3 | C29H25N5O3 | 1803357-22-3 | Details |
Peldesine | C12H11N5O | 133432-71-0 | Details |
PDE1-IN-2 | C16H21BrN4O2 | 1904611-63-7 | Details |
Penbutolol sulfate | C44H76N2O8S | 38363-32-5 | Details |
PDE9-IN-1 | C17H23FN6O2 | 2305087-92-5 | Details |
Indacaterol maleate | C24H28N2O3.C4H4O4 | 753498-25-8 | Details |
CCK-A receptor inhibitor 1 | C25H35NO6S | 137004-80-9 | Details |
PD 168568 dihydrochloride | C22H28ClN3O | 1782532-06-2 | Details |
MP7 | C28H22F2N4O4 | 1001409-50-2 | Details |
Flumazenil | C15H14FN3O3 | 78755-81-4 | Details |
Altretamine | C9H18N6 | 645-05-6 | Details |
PDK4-IN-1 hydrochloride | C22H20ClN3O2 | 2310262-11-2 | Details |
Phenylacetylglutamine-D5;NSC 203800-D5;Phenylacetyl-L-glutamine-D5 | C13H11D5N2O4 | 1331909-01-3 | Details |
PF429242 dihydrochloride | C25H36ClN3O2 | 2248666-66-0 | Details |
PF-00356231 hydrochloride | C25H21ClN2O3S | 820223-77-6 | Details |
PfDHODH-IN-1 | C14H11F3N2O2 | 183945-55-3 | Details |
PF-543 Citrate;Sphingosine Kinase 1 Inhibitor II Citrate | C33H39NO11S | 1415562-83-2 | Details |
PF-04885614 | C13H14F3N3O | 1480833-70-2 | Details |
PF-04634817 | C25H36F3N5O3 | 1228111-63-4 | Details |
Adriforant hydrochloride;PF-3893787 hydrochloride | C13H25ClN6O | 2096455-90-0 | Details |
PF-06952229 | C23H24ClFN4O3 | 1801333-55-0 | Details |
Phortress free base | C20H23FN4OS | 741241-36-1 | Details |
Phenelzine sulfate | C8H14N2O4S | 156-51-4 | Details |
Alvimopan | C25H32N2O4 | 156053-89-3 | Details |
PF-00446687 | C28H36F2N2O2 | 862281-92-3 | Details |
PF-06424439 methanesulfonate | C23H30ClN7O4S | 1469284-79-4 | Details |
PF-04634817 succinate | C29H42F3N5O7 | 2140301-98-8 | Details |
PF-06305591 | C15H22N4O | 1449473-97-5 | Details |
Pentosan Polysulfate Sodium (W/W 43%);Pentosan Polysulfate Sodium | 140207-93-8 | Details |
PF-06882961 | C31H30FN5O4 | 2230198-02-2 | Details |
Pentosan Polysulfate | C10H18O21S4 | 37300-21-3 | Details |
Phenindione D5;Rectadione D5 | C15H5D5O2 | 70711-53-4 | Details |
PF-04957325 | C14H15F3N8OS | 1305115-80-3 | Details |
PF-03654746 Tosylate | C25H32F2N2O4S | 1039399-17-1 | Details |
Phentolamine Analogue 1 | C17H19N3O | 47142-51-8 | Details |
PF-06726304 | C22H21Cl2N3O3 | 1616287-82-1 | Details |
PF-06424439 | C22H26ClN7O | 1469284-78-3 | Details |
Phenserine;(-)-Eseroline phenylcarbamate;(-)-Phenserine | C20H23N3O2 | 101246-66-6 | Details |
Phenolic acid | 29656-58-4 | Details |
Hydrocortisone acetate;Cortisol 21-acetate;Hydrocortisone 21-acetate | C23H32O6 | 50-03-3 | Details |
PF-04217903 phenolsulfonate | C25H22N8O5S | 1159490-85-3 | Details |
PF-06256142 | C21H16N4O2 | 1609583-14-3 | Details |
PF-06726304 acetate | C24H25Cl2N3O5 | 2080306-28-9 | Details |
PETCM | C8H8Cl3NO | 10129-56-3 | Details |
Antitumor agent-4 | C29H36NO5P | 115767-64-1 | Details |
Colistin sulfate | 2(C52H98N16O13).5(H2SO4) | 1264-72-8 | Details |
PF-04217903 methanesulfonate | C20H20N8O4S | 956906-93-7 | Details |
PF-06751979 | C18H19F2N5O3S2 | 1818339-66-0 | Details |
Phomopsin A | C36H45ClN6O12 | 64925-80-0 | Details |
Brepocitinib P-Tosylate | C25H29F2N7O4S | 2140301-96-6 | Details |
Product Total: Product Page: | ||||
16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 |